Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2011-10-31

FDA Approved: ROPINIROLE — Supplemental Application (Alembic Pharmaceuticals Limited)

View source ↗

Summary

The FDA approved a supplemental application for ropinirole from Alembic Pharmaceuticals Limited, indicating an update to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ropinirole (ropinirole)

Snippet

SUPPL AP for ROPINIROLE (ROPINIROLE)